Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|14|1168-1178

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.14, 2013-11, pp. : 1168-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: “Amniotic Fluid Embolism: Novel Biomarkers for Future Diagnostic Investigation and Therapy”)

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 14, 2013-11 ,pp. : 1155-1156

Bentham Science Publishers

Access to resources Recommend Favorite

Amniotic Fluid Embolism: Review

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 14, 2013-11 ,pp. : 1163-1167

Bentham Science Publishers

Access to resources Recommend Favorite

Testing challenges: evaluation of novel diagnostics and molecular biomarkers

By Zimmern Ronald L  

Clinical Medicine, Vol. 9, Iss. 1, 2009-02 ,pp. : 68-73

Royal College Of Physicians

Access to resources Recommend Favorite

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

By Jain Surbhi   Wojdacz Tomasz K   Su Ying-Hsiu  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 3, 2013-04 ,pp. : 283-294

Informa Healthcare

Access to resources Recommend Favorite

Not Only a Clinical Nightmare: Amniotic Fluid Embolism in Court

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 14, 2013-11 ,pp. : 1195-1200

Bentham Science Publishers

Access to resources Recommend Favorite